Clinical Trial 55037

Berlin, NJ 08009


Summary:

A phase III, multicentre, randomised, double-blind,controlled study to investigate the efficacy, safety,and tolerability of two administrations of COMP360 in participants with treatment-resistant depression


Qualified Participants Must:

• Be at least 18 years old
• Have been diagnosed with major depression (single or recurrent episodes)
• if a single episode, it should be a duration between 3 months and 2 years
• Are experiencing treatment-resistant depression, defined as failing 2, 3 or 4 pharmacological treatments for their current episode of depression
• Other criteria will need to be met to confirm a participant's eligibility for COMP 006 study


Qualified Participants May Receive:

Up to $1,225 for eligible participants


Available At:

CenExel HRI
175 Berlin-Cross Keys Rd. Suite 109
Berlin, NJ 08009
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.